Consistent with these results, IHC analysis of tumor xenografts indicated that the combination treatment with epirubicin and R428 induced the lowest Ki‐67 (Fig. 6D,E) and the highest cleaved caspase‐3 (Fig. 6F,G) protein levels relative to single treatments with either drugs. Here, MKI67 is linked to neoplasm.